Patents by Inventor Ryan E. Piktel

Ryan E. Piktel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8288111
    Abstract: The present disclosure provides among other things immunoassays exhibiting reduced cross-reactivity with analyte metabolites. Additionally, the present disclosure provides diagnostic immunoassays to determine the concentration or level in a test sample of a hydrophobic drug that metabolizes in vivo or in vitro to form cross-reacting metabolites wherein cross-reactivity with such metabolites of the drug analyte is reduced. In particular, the disclosure provides such immunoassays where the hydrophobic drug is an immunosuppressant drug such as cyclosporine A.
    Type: Grant
    Filed: May 23, 2008
    Date of Patent: October 16, 2012
    Assignee: Abbott Laboratories
    Inventors: Elaine M. Brate, David M. Finley, Shelley R. Holets-McCormack, David P. Pacenti, Ryan E. Piktel, Michelle L. Shields, Thomas G. Spring, Phillip P. Wang
  • Publication number: 20080311676
    Abstract: The present disclosure provides among other things immunoassays exhibiting reduced cross-reactivity with analyte metabolites. Additionally, the present disclosure provides diagnostic immunoassays to determine the concentration or level in a test sample of a hydrophobic drug that metabolizes in vivo or in vitro to form cross-reacting metabolites wherein cross-reactivity with such metabolites of the drug analyte is reduced. In particular, the disclosure provides such immunoassays where the hydrophobic drug is an immunosuppressant drug such as cyclosporine A.
    Type: Application
    Filed: May 23, 2008
    Publication date: December 18, 2008
    Applicant: ABBOTT LABORATORIES
    Inventors: Elaine M. Brate, David M. Finley, Shelley R. Holets-McCormack, David P. Pacenti, Ryan E. Piktel, Michelle Shields, Thomas G. Spring, Philip P. Wang